| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/20/2005 | WO2004015057A3 Mucin-immunoglobulin fusion proteins |
| 01/20/2005 | WO2003068821A3 Anti-cd20 antibodies and fusion proteins thereof and methods of use |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2003057155A3 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 01/20/2005 | WO2003035848A9 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050014934 Modified immunoglobulin receptor for use as enhanced indicator tool immunological detection; protein detection |
| 01/20/2005 | US20050014931 A monoclonal antibody or an antigen-binding fragment thereof that specifically binds the capsular polysaccharide of Streptococcus pneumoniae serotype PPS 3; heavy chain amino acid sequence as well as DNA encoding it; complementary determining regions; pneumonia; passive immunizations; diagnosis/medical/ |
| 01/20/2005 | US20050014785 Treatment of radiation disorders |
| 01/20/2005 | US20050014733 Therapeutic and prophylactic methods for neuromuscular disorders |
| 01/20/2005 | US20050014718 Tumor specific oligosaccharide sequences and use thereof |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014687 Nucleoc acid sequences coding polypeptides; binding to antibodies; diagnosis, therapy of diseases such as cancer |
| 01/20/2005 | US20050014230 Generating immunoglobulin specific for human lymphadenopathy viral glycoprotein 120 for use in prevention and treatment of viral diseases; immunotherapy |
| 01/20/2005 | US20050014229 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 01/20/2005 | US20050014228 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 01/20/2005 | US20050014226 Using monoclonal antibodies specific to membrane bound receptors as diagnostic indicator of abnormal cell proliferation; tumor diagnosis; antitumor agents |
| 01/20/2005 | US20050014224 GITR ligand and GITR ligand-related molecules and antibodies and uses thereof |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014210 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 01/20/2005 | US20050014208 Using presence of tumor marker proteins as diagnostic and/or prognostic tools in diagnosis and treatment of cell proliferative disorders; immunodiagnostics |
| 01/20/2005 | US20050014207 Monoclonal antibody hPAM4 |
| 01/20/2005 | US20050014203 Liquid tissue preparation from histopathologically processed biological samples, tissues and cells |
| 01/20/2005 | US20050014194 Use of insulin response modulators in the treatment of diabetes and insulin resistance |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | US20050014169 Nuclease inhibitor cocktail |
| 01/20/2005 | US20050014139 Human cyclin I and genes encoding same |
| 01/20/2005 | US20050013827 Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof |
| 01/20/2005 | US20050013824 Use of highly Immunodominant central nervous system myelin protein; inducing tolerance |
| 01/20/2005 | US20050013819 Use of EphA4 and modulator of EphA4 for diagnosis, treatment and prevention of cancer |
| 01/20/2005 | US20050013817 Human SMAPK3-related gene variants associated with cancers |
| 01/20/2005 | US20050013816 Antibodies or active fragments specific for MORT-1 (Mediator of Receptor Toxicity) protein having amino acid sequence 2; tumors, hiv |
| 01/20/2005 | US20050013815 Prevention and treatment of amyloidogenic disease |
| 01/20/2005 | US20050013813 Down Syndrome; and also include Alzheimer's Disease |
| 01/20/2005 | US20050013811 Enhancement of immune responses by 4-1bb-binding agents |
| 01/20/2005 | US20050013809 Antibodies against drugs of abuse |
| 01/20/2005 | US20050013800 Inhibiting ligand/receptor interactions involving immunoglobulins, interleukins, interferon-alpha, histamine and/or leukotrienes; long term relief; kits |
| 01/20/2005 | US20050013799 Using combination of IgE immunoglobulin inhibitor and antihistamine; kits |
| 01/20/2005 | US20050013796 Detection and treatment of breast disease |
| 01/20/2005 | DE10330235A1 Neues Eimeria Gen und Protein sowie deren Verwendung New Eimeria gene and protein and their use |
| 01/20/2005 | CA2541753A1 Combination therapy for gastroenteric diseases caused by microorganisms |
| 01/20/2005 | CA2536354A1 Atopic dermatitis inducer |
| 01/20/2005 | CA2532535A1 Method of diagnosing disease relating to endometriosis |
| 01/20/2005 | CA2532173A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 01/20/2005 | CA2531962A1 Emitter-binding peptides that produce a change in the spectral emission properties of the emitter |
| 01/20/2005 | CA2531482A1 Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses |
| 01/20/2005 | CA2531283A1 Specific human antibodies |
| 01/20/2005 | CA2531235A1 Applications of a new class of enzymes: sulfiredoxines. |
| 01/20/2005 | CA2531222A1 Novel hcv core+1 protein, methods for diagnosis of hcv infections, prophylaxis, and for screening of anti-hcv agents |
| 01/20/2005 | CA2531161A1 Use of a novel eimeria gene and corresponding protein |
| 01/20/2005 | CA2531118A1 Multivalent carriers of bi-specific antibodies |
| 01/20/2005 | CA2530980A1 Tissue factor-specific antibodies for preventing or treating acute lung injury or acute respiratory distress syndrome |
| 01/20/2005 | CA2526402A1 Blys antagonists and uses thereof |
| 01/20/2005 | CA2524771A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor |
| 01/19/2005 | EP1498491A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO Fc GAMMA RECEPTOR IIIa |
| 01/19/2005 | EP1498490A1 Process for producing antibody composition |
| 01/19/2005 | EP1498485A1 Cells with modified genome |
| 01/19/2005 | EP1498482A2 Crystal structure of oxidosqualene cyclase |
| 01/19/2005 | EP1498429A2 Rationally designed antibodies |
| 01/19/2005 | EP1498428A1 Antibodies for detecting ecstasy-class analytes |
| 01/19/2005 | EP1498427A1 Immunoglobulins devoid of light chains |
| 01/19/2005 | EP1498426A1 Preparation of fully human antibodies |
| 01/19/2005 | EP1498415A1 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 01/19/2005 | EP1498137A1 Remedy for lung cancer |
| 01/19/2005 | EP1498133A1 Use of a pak inhibitor for the treatment of a joint disease |
| 01/19/2005 | EP1497659A2 An ephrin-b receptor protein involved in carcinoma |
| 01/19/2005 | EP1497658A2 Protein involved in cancer |
| 01/19/2005 | EP1497656A2 Diagnosis of carcinoma using raig1 polypeptides |
| 01/19/2005 | EP1497654A2 Immunoglobulin e vaccines and methods of use thereof |
| 01/19/2005 | EP1497653A2 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl) |
| 01/19/2005 | EP1497649A2 Antibodies specific for mucin polypeptide |
| 01/19/2005 | EP1497647A1 Test for measurement of therapeutic drug levels |
| 01/19/2005 | EP1497646A2 Peptide biomarker and method of identification |
| 01/19/2005 | EP1497467A2 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 01/19/2005 | EP1497454A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
| 01/19/2005 | EP1497445A2 Antibodies that specifically bind to gmad |
| 01/19/2005 | EP1497427A2 Helicokinin-receptor from insects |
| 01/19/2005 | EP1497425A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 01/19/2005 | EP1497423A2 Mcp-1 mutant proteins, antibodies, compositions, methods and uses |
| 01/19/2005 | EP1497422A2 La1 - the genome of a lactobacillus strain |
| 01/19/2005 | EP1497418A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 01/19/2005 | EP1497415A2 Cytokine receptor |
| 01/19/2005 | EP1497413A1 Methods for producing immortalised antibodies-secreting cells |
| 01/19/2005 | EP1497333A2 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 01/19/2005 | EP1497332A1 Bispecific antibody binding tcr and tirc7 and its use in therapy and diagnosis |
| 01/19/2005 | EP1497331A2 Multispecific binding molecules |
| 01/19/2005 | EP1497330A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein |
| 01/19/2005 | EP1497319A2 Cell adhesion and extracellular matrix proteins |
| 01/19/2005 | EP1497318A2 Binding molecules for fc-region polypeptides |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1497305A2 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes |
| 01/19/2005 | EP1496945A1 Mycoplasma polypeptides |
| 01/19/2005 | EP1496937A2 Dna vaccine combined with an inducer of tumor cell apoptosis |
| 01/19/2005 | EP1496932A2 Anti-hiv composition, production method thereof and medicament |
| 01/19/2005 | EP1496923A1 Cancer immunotherapy |
| 01/19/2005 | EP1496886A1 Knockout mice and their use |
| 01/19/2005 | EP1496834A2 High affinity integrin polypeptides and uses thereof |
| 01/19/2005 | EP1496743A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/19/2005 | EP1463942A4 Methods for purifying protein |
| 01/19/2005 | EP1416963A4 Treating, preventing, or detecting angiogenesis with an anti-a2b antibody |